These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17710682)

  • 21. Helicobacter pylori infection in pathogenesis of gastroesophageal reflux disease.
    Thor PJ; Błaut U
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():81-90. PubMed ID: 17033107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helicobacter pylori infection and antisecretory efficacy of proton-pump inhibitors in gastroesophageal reflux disease: a liaison dangereuse or an innocent interplay?
    Parente FR; Bargiggia SA; Anderloni A
    Scand J Gastroenterol; 2006 Oct; 41(10):1121-5. PubMed ID: 16990195
    [No Abstract]   [Full Text] [Related]  

  • 23. Predictive role of nuclear factor-kappaB activity in gastric cancer: a promising adjuvant approach with caffeic acid phenethyl ester.
    Wu CS; Chen MF; Lee IL; Tung SY
    J Clin Gastroenterol; 2007; 41(10):894-900. PubMed ID: 18090157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New aspects of Helicobacter pylori infection involvement in gastric oncogenesis.
    Kountouras J; Zavos C; Chatzopoulos D; Katsinelos P
    J Surg Res; 2008 May; 146(1):149-58. PubMed ID: 17720195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Barrett esophagus: current state of the problem].
    Belova GV; Sokolov VV; Budzinskiĭ AA; Mel'chenko DS
    Eksp Klin Gastroenterol; 2007; (3):36-44. PubMed ID: 17937004
    [No Abstract]   [Full Text] [Related]  

  • 26. Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer.
    Kitajima Y; Ohtaka K; Mitsuno M; Tanaka M; Sato S; Nakafusa Y; Miyazaki K
    Oncol Rep; 2008 Jan; 19(1):197-202. PubMed ID: 18097595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study.
    Anderson LA; Murphy SJ; Johnston BT; Watson RG; Ferguson HR; Bamford KB; Ghazy A; McCarron P; McGuigan J; Reynolds JV; Comber H; Murray LJ
    Gut; 2008 Jun; 57(6):734-9. PubMed ID: 18025067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer.
    Talley NJ; Fock KM; Moayyedi P
    Am J Gastroenterol; 2008 Mar; 103(3):510-4. PubMed ID: 18341483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism for gastric cancer development by Helicobacter pylori infection.
    Chiba T; Marusawa H; Seno H; Watanabe N
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1175-81. PubMed ID: 18637055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Gastroesophageal reflux disease and malignancy].
    Richert Z; Robaszkiewicz M
    Rev Prat; 2008 Sep; 58(13):1414-5, 1417, 1419-20. PubMed ID: 18924321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barrett's esophagus (BE) and carcinoma in the esophageal stump (ES) after esophagectomy with gastric pull-up in achalasia patients: a study based on 10 years follow-up.
    da Rocha JR; Ribeiro U; Sallum RA; Szachnowicz S; Cecconello I
    Ann Surg Oncol; 2008 Oct; 15(10):2903-9. PubMed ID: 18618179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors responsible for the increasing incidence of oesophageal adenocarcinoma.
    Desai HG; Kamani PM
    J Assoc Physicians India; 2007 Jun; 55():435-7. PubMed ID: 17879499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis.
    Rokkas T; Pistiolas D; Sechopoulos P; Robotis I; Margantinis G
    Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1413-7, 1417.e1-2. PubMed ID: 17997357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acid reflux and cancer. How they may be connected.
    Mayo Clin Womens Healthsource; 2006 Nov; 10(11):6. PubMed ID: 17047567
    [No Abstract]   [Full Text] [Related]  

  • 35. Decreased IgA antibody production in the stomach of gastric adenocarcinoma patients.
    Quiding-Järbrink M; Sundström P; Lundgren A; Hansson M; Bäckström M; Johansson C; Enarsson K; Hermansson M; Johnsson E; Svennerholm AM
    Clin Immunol; 2009 Jun; 131(3):463-71. PubMed ID: 19249247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Barrett's esophagus.
    J Pract Nurs; 2008; 58(3):19-20. PubMed ID: 19180846
    [No Abstract]   [Full Text] [Related]  

  • 37. Autocrine extra-pancreatic trypsin 3 secretion promotes cell proliferation and survival in esophageal adenocarcinoma.
    Han S; Lee CW; Trevino JG; Hughes SJ; Sarosi GA
    PLoS One; 2013; 8(10):e76667. PubMed ID: 24146905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Any role for endoscopy screening or surveillance for esophageal adenocarcinoma among persons with GERD?
    Lagergren J
    Gastrointest Endosc; 2008 Nov; 68(5):856-8. PubMed ID: 18984099
    [No Abstract]   [Full Text] [Related]  

  • 39. Biopsy site for detecting Helicobacter pylori infection in patients with gastric cancer.
    Kim CG; Choi IJ; Lee JY; Cho SJ; Nam BH; Kook MC; Hong EK; Kim YW
    J Gastroenterol Hepatol; 2009 Mar; 24(3):469-74. PubMed ID: 19067779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of the complications of gastroesophageal reflux disease.
    Belhocine K; Galmiche JP
    Dig Dis; 2009; 27(1):7-13. PubMed ID: 19439954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.